Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

Panteleimon E. Papakonstantinou; Josip A. Borovac; Aleksandra Gasecka; Dario Bongiovanni; Hanne Ehrlinder; Michela Giustozzi; William A. E. Parker; Rui Azevedo Guerreiro

doi:https://doi.org/10.1093/eurjpc/zwab021

Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

Panteleimon E. Papakonstantinou, Josip A. Borovac, Aleksandra Gasecka, Dario Bongiovanni, Hanne Ehrlinder, Michela Giustozzi, William A. E. Parker, Rui Azevedo Guerreiro

Research output: Contribution to journal › Comment/Letter to the editor › Academic

7 Citations (Scopus)

Original language	English
Article number	zwab021
Journal	European Journal of Preventive Cardiology
Early online date	2021
DOIs	https://doi.org/10.1093/eurjpc/zwab021
Publication status	E-pub ahead of print - 2021

Access to Document

https://doi.org/10.1093/eurjpc/zwab021

Cite this

Papakonstantinou, P. E., Borovac, J. A., Gasecka, A., Bongiovanni, D., Ehrlinder, H., Giustozzi, M., Parker, W. A. E., & Guerreiro, R. A. (2021). Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy? European Journal of Preventive Cardiology, [zwab021]. https://doi.org/10.1093/eurjpc/zwab021

@article{39618da3353a4e7285b4310e95068216,

title = "Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?",

author = "Papakonstantinou, {Panteleimon E.} and Borovac, {Josip A.} and Aleksandra Gasecka and Dario Bongiovanni and Hanne Ehrlinder and Michela Giustozzi and Parker, {William A. E.} and Guerreiro, {Rui Azevedo}",

year = "2021",

doi = "https://doi.org/10.1093/eurjpc/zwab021",

language = "English",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4881",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era

T2 - Is it time to reconsider our therapeutic strategy?

AU - Papakonstantinou, Panteleimon E.

AU - Borovac, Josip A.

AU - Gasecka, Aleksandra

AU - Bongiovanni, Dario

AU - Ehrlinder, Hanne

AU - Giustozzi, Michela

AU - Parker, William A. E.

AU - Guerreiro, Rui Azevedo

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85114910640&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/eurjpc/zwab021

DO - https://doi.org/10.1093/eurjpc/zwab021

M3 - Comment/Letter to the editor

C2 - 33564838

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4881

M1 - zwab021

ER -

Anticoagulation therapy in non-valvular atrial fibrillation in the covid-19 era: Is it time to reconsider our therapeutic strategy?

Access to Document

Other files and links

Cite this